Levothyroxine Sodium Tablets 300 mcg
Accord Healthcare is recalling 300 mcg Levothyroxine Sodium Tablets due to subpotency.
Contact your healthcare provider or pharmacist to discuss alternative treatment options and return the affected medication to your pharmacy.
Why it was recalled
Accord Healthcare is recalling Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg) due to the product being subpotent. This recall affects the 90-count bottle presentation.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.
- Recall #
- D-0656-2026
Where it was sold
Distributed nationwide.
Official source
Editorial summary by Recall Canary · last updated 2026-07-01 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification